Genomics England has today announced the appointment of Chris Wigley as Chief Executive Officer, with effect from 1 October.
Chris joins Genomics England from QuantumBlack, a world leader in machine learning and artificial intelligence. Machine learning is critical in the analysis of the vast amounts of data involved in genomics, so Chris’ expertise in this area will be invaluable in driving Genomics England’s pioneering work with the NHS to realise the true potential of genomic medicine.
Chris was a Partner at McKinsey from 2009 to 2015. He then focused on growing QuantumBlack, a McKinsey company, as Chief Operating Officer. Prior to this, he worked with the British Foreign Office as a diplomat, and on digital transformation at the BBC.
The Chair of Genomics England, Jonathan Symonds CBE, said:
Sir Mark Caulfield, who has acted as Interim CEO, will continue his excellent strategic scientific and clinical leadership as Chief Scientist in the next phase of transformation of genomic medicine in the NHS.
Jonathan Symonds said:
Matt Hancock, Secretary of State for Health and Social Care, said:
Baroness Blackwood, Parliamentary Under Secretary of State, said: